Ended 2014. Since may of this year, Russia lives in the face of economic sanctions imposed by the US and EU countries due to the annexation of Crimea and subsequent events in Ukraine. Interest features of the existence of the pharmaceutical market in the changed political and economic conditions.
To understand the prospects for the development of the Russian pharmaceutical market in 2015 and subsequent years should analyse the situation in the industry in previous years. It should be noted that:
- the Global economy is currently in a period of recovery from the global crisis.
- the Pharmaceutical market is one of the lucrative and growing sector of the global economy.
- the Russian pharmaceutical market is closely integrated segment in the global pharmaceutical market,
- Looking at the relationship of Russia and the countries, which have imposed sanctions, it should be noted that 90% of sports nutrition in Russia deliver us and canadian firms. More than 450 Western manufacturers are actively working on the Russian market with a total expected realisation of more than 15 billion U.S. dollars in 2014.
- Large Western pharmaceutical company organized the production of medicines in Russia, actively cooperate with the Russian scientific laboratories.
- Dynamics of development of pharmaceutical industry in Russia is a socially-oriented policy of the state. The expenditure budget for 2015 for health care is estimated at $ 2718,6 billion. Active development of health insurance increases the accessibility of the population to costly high-tech treatments. Construction in many regions of centres to provide high-tech medical aid to the population in different areas of medicine requires a larger amount of imported equipment and medical supplies.
- Given the history of economic sanctions against a number of States such as Cuba, Iraq, Iran, etc. it should be noted that the limitations do not spread to medical. Technology.
- By IMS Health forecast, by 2017, Russia will occupy the eighth place in the world in terms of pharmaceutical market.
the Forecast and its justification.
the Extension of sanctions restrictions on the pharmaceutical market in Russia is unlikely for the following reasons:
- Sanctions harm not only Russia, but also of the States participants of the imposition of sanctions, slowing the pace of recovery from the global crisis.
- the Application of sanctions against the Russian pharmaceutical market can be a cause of its loss to Western manufacturers, social tensions within these countries.
- Investors and Western pharmaceutical companies doing business in Russia are interested to profit from the earlier investment. To ensure sustainable development of the Russian pharmaceutical market is now important to reduce the gap between supply and demand on the labour market resulting from demographic crisis of the 1990s. Development and implementation of methods of promotion of medicines from the manufacturer to the direct consumers.
Tatiana Selezneva
Recruiting company AVICONN
Head of sales Department
